Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Mifepristone increases gamma-retroviral infection efficiency by enhancing the integration of virus into the genome of infected cells

Abstract

Gamma-retroviruses are commonly used to deliver genes to cells. Previously, we demonstrated that the synthetic anti-glucocorticoid and anti-progestin agent, mifepristone, increased gamma-retroviral infection efficiency in different target cells, independent of viral titer. In this study, we examine how this occurs. We studied the effect of mifepristone on different steps of viral infection (viral entry, viral survival, viral DNA synthesis and retrovirus integration into the host genome) in three distinct retroviral backbones using different virus recognition receptors. We also tested the potential role of glucocorticoid and progesterone receptors in mediating mifepristone's ability to increase gamma-retroviral infectivity. We show that mifepristone increases gamma-retroviral infection efficiency by facilitating viral integration into the host genome and that this effect seems to be due to mifepristone's anti-glucocorticoid, but not its anti-progestin, activity. These results suggest that inhibition of the glucocorticoid receptor enhances retroviral integration into the host genome and indicates that cells may have a natural protection again retroviral infection that may be reduced by glucocorticoid receptor antagonists.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Solodushko V, Bitko V, Fouty B . Dexamethasone and mifepristone increase retroviral infectivity through different mechanisms. Am J Physiol Lung Cell Mol Physiol 2009; 297: L538–L545.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. D’Souza V, Summers MF . Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature 2004; 431: 586–590.

    Article  PubMed  Google Scholar 

  3. Hawley RG, Hawley TS, Fong AZ, Quinto C, Collins M, Leonard JP et al. Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11. Proc Natl Acad Sci USA 1996; 93: 10297–10302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Baum C, Eckert HG, Stockschlader M, Just U, Hegewisch-Becker S, Hildinger M et al. Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection. J Hematother 1996; 5: 323–329.

    Article  CAS  PubMed  Google Scholar 

  5. Simons K, Garoff H . The budding mechanisms of enveloped animal viruses. J Gen Virol 1980; 50: 1–21.

    Article  CAS  PubMed  Google Scholar 

  6. Kim JW, Closs EI, Albritton LM, Cunningham JM . Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 1991; 352: 725–728.

    Article  CAS  PubMed  Google Scholar 

  7. Kozak SL, Siess DC, Kavanaugh MP, Miller AD, Kabat D . The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J Virol 1995; 69: 3433–3440.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Emi N, Friedmann T, Yee JK . Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 1991; 65: 1202–1207.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Lavillette D, Boson B, Russell SJ, Cosset FL . Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J Virol 2001; 75: 3685–3695.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lim RY, Aebi U, Stoffler D . From the trap to the basket: getting to the bottom of the nuclear pore complex. Chromosoma 2006; 115: 15–26.

    Article  PubMed  Google Scholar 

  11. Miller DG, Adam MA, Miller AD . Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239–4242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Andreadis ST, Brott D, Fuller AO, Palsson BO . Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5–7.5 h. J Virol 1997; 71: 7541–7548.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Menendez-Arias L, Berkhout B . Retroviral reverse transcription. Virus Res 2008; 134: 1–3.

    Article  CAS  PubMed  Google Scholar 

  14. Spitz IM, Bardin CW . Mifepristone (RU 486)—a modulator of progestin and glucocorticoid action. N Engl J Med 1993; 329: 404–412.

    Article  CAS  PubMed  Google Scholar 

  15. Cadepond F, Ulmann A, Baulieu EE . RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 1997; 48: 129–156.

    Article  CAS  PubMed  Google Scholar 

  16. Thomson F, Craighead MW, Watson L, Turnbull Z, McIntosh L, Speake M et al. The compounds Org 34517 and Org 34850 are potent antagonists of the glucocorticoid receptor both in vitro and in vivo. J Eur Coll Neuropsychopharmacol 2003; 13: S229.

    Article  Google Scholar 

  17. Jin C, Manikumar G, Kepler JA, Cook CE, Allan GF, Kiddoe M et al. Synthesis and identification of novel 11beta-aryl-4′,5′-dihydrospiro[estra-4,9-diene-17beta,4′-oxazole] analogs with dissociated antiprogesterone activities. Bioorg Med Chem Lett 2007; 17: 5754–5757.

    Article  CAS  PubMed  Google Scholar 

  18. Pinski J, Halmos G, Shirahige Y, Wittliff JL, Schally AV . Inhibition of growth of the human malignant glioma cell line (U87MG) by the steroid hormone antagonist RU486. J Clin Endocrinol Metab 1993; 77: 1388–1392.

    CAS  PubMed  Google Scholar 

  19. Attardi BJ, Zeleznik A, Simhan H, Chiao JP, Mattison DR, Caritis SN . Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol 2007; 197: 599 e591-597.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kinyamu HK, Fryer CJ, Horwitz KB, Archer TK . The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptor. J Biol Chem 2000; 275: 20061–20068.

    Article  CAS  PubMed  Google Scholar 

  21. Krishan A . Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 1975; 66: 188–193.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study financially supported by funds from National Heart Lung Blood Institute/NIH RO1 award, RO1 HL70273-01 and by a Grant-in-Aid from the American Heart Association.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V Solodushko.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Solodushko, V., Fouty, B. Mifepristone increases gamma-retroviral infection efficiency by enhancing the integration of virus into the genome of infected cells. Gene Ther 17, 1253–1261 (2010). https://doi.org/10.1038/gt.2010.80

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2010.80

Keywords

This article is cited by

Search

Quick links